These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 27150044)

  • 1. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
    Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
    Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
    Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
    Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites.
    Hyde JE
    Pharmacol Ther; 1990; 48(1):45-59. PubMed ID: 2274577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
    Nirmalan N; Sims PF; Hyde JE
    Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. folA thyA knockout E. coli as a suitable surrogate model for evaluation of antifolate sensitivity against PfDHFR-TS.
    Suwanakitti N; Talawanich Y; Vanichtanankul J; Taweechai S; Yuthavong Y; Kamchonwongpaisan S; Kongkasuriyachai D
    Acta Trop; 2024 Oct; 258():107360. PubMed ID: 39142549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
    de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
    Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
    Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
    Malar J; 2011 May; 10():119. PubMed ID: 21554743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
    J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
    Fohl LM; Roos DS
    Mol Microbiol; 2003 Nov; 50(4):1319-27. PubMed ID: 14622418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible knockdown of Plasmodium gene expression using the glmS ribozyme.
    Prommana P; Uthaipibull C; Wongsombat C; Kamchonwongpaisan S; Yuthavong Y; Knuepfer E; Holder AA; Shaw PJ
    PLoS One; 2013; 8(8):e73783. PubMed ID: 24023691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials.
    Brobey RK; Sano G; Itoh F; Aso K; Kimura M; Mitamura T; Horii T
    Mol Biochem Parasitol; 1996 Oct; 81(2):225-37. PubMed ID: 8898337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
    Zhang K; Rathod PK
    Science; 2002 Apr; 296(5567):545-7. PubMed ID: 11964483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Plasmodium knowlesi dihydrofolate reductase-thymidylate synthase and sensitivity to antifolates.
    Ittarat W; Pornthanakasem W; Mungthin M; Suwandittakul N; Leelayoova S; Tarnchompoo B; Yuthavong Y; Kongkasuriyachai D; Leartsakulpanich U
    Parasitol Int; 2018 Dec; 67(6):787-792. PubMed ID: 30114522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
    Wu Y; Kirkman LA; Wellems TE
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1130-4. PubMed ID: 8577727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
    Wooden JM; Hartwell LH; Vasquez B; Sibley CH
    Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
    O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
    J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial target vulnerability of the putative
    Leela N; Prommana P; Kamchonwongpaisan S; Taechalertpaisarn T; Shaw PJ
    PeerJ; 2024; 12():e16595. PubMed ID: 38239295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum.
    Wang P; Nirmalan N; Wang Q; Sims PF; Hyde JE
    Mol Biochem Parasitol; 2004 May; 135(1):77-87. PubMed ID: 15287589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial effect of cell penetrating peptides derived from the junctional region of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
    Chaianantakul N; Sungkapong T; Supatip J; Kingsang P; Kamlaithong S; Suwanakitti N
    Peptides; 2020 Sep; 131():170372. PubMed ID: 32673701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.